Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual Oncology Innovation Forum
May 22, 2024 07:00 ET
|
Medicenna Therapeutics Corp.
TORONTO and HOUSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused...
Ensurge Micropower ASA - Registration of Share Capital Increase
May 22, 2024 05:14 ET
|
Ensurge Micropower ASA
Oslo, 22 May 2024 Reference is made to the announcement by Ensurge Micropower ASA (the "Company") on 13 May 2024 regarding a successful private placement of shares ("Private Placement"), through an...
LIFT intersects 35 m at 1.32% Li2O at its Shorty pegmatite, Yellowknife Lithium Project, NWT
May 22, 2024 03:05 ET
|
Li-FT Power Ltd.
VANCOUVER, British Columbia, May 22, 2024 (GLOBE NEWSWIRE) -- Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to report assays from 12 drill holes...
Lleida.net sales increase 7% in the first 4 months of 2024, up to 6.3 million euros
May 22, 2024 02:15 ET
|
LLeida.net
Madrid, 22 May. - Revenues at listed technology company Lleida.net (OTCQX:LLEIF) (BME:LLN) (EPA:ALLLN) rose seven per cent in the first four months of 2024, compared to the same period last year. In...
Le chiffre d'affaires net de Lleida.augmente de 7 % au cours des 4 premiers mois de 2024, pour atteindre 6,3 millions d'euros
May 22, 2024 02:15 ET
|
LLeida.net
Madrid, 22 mai. - Les revenus de la société technologique cotée Lleida.net (OTCQX:LLEIF) (BME:LLN) (EPA:ALLLN) ont augmenté de 7 % au cours des quatre premiers mois de 2024, par rapport à la même...
Las ventas de Lleida.net aumentan un 7% en los primeros 4 meses de 2024, hasta los 6,3 millones de euros
May 22, 2024 02:15 ET
|
LLeida.net
Madrid, 22 de mayo. - Las ventas de la cotizada tecnológica Lleida.net (OTCQX:LLEIF) (BME:LLN) (EPA:ALLLN) registraron un incremento del siete por ciento en los primeros cuatro meses de 2024, respecto...
Transaction in Own Shares
May 22, 2024 01:30 ET
|
Endeavour Mining PLC
ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 22 May 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of...
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe
May 22, 2024 01:00 ET
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all...
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk
May 22, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics...
Carbon Streaming Announces Landmark Azuero Reforestation Carbon Removal Project in Collaboration With Rubicon Carbon, Ponterra, and Microsoft
May 21, 2024 20:00 ET
|
Carbon Streaming Corporation
Carbon Streaming Announces Landmark Azuero Reforestation Carbon Removal Project In Collaboration With Rubicon Carbon, Ponterra, And Microsoft